Carlsmed Affirms FY2026 Sales Guidance of $74.000M-$78.000M vs $74.830M Est

Carlsmed (NASDAQ: CARL ) affirms FY2026 sales outlook from $74.000 million-$78.000 million to $74.000 million-$78.000 million vs $74.830 million estimate.